Clinical Trial Update: Mitigating the Pro-inflammatory Phenotype of Obesity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from the University of Kansas Medical Center aims to mitigate the pro-inflammatory phenotype of obesity and related metabolic condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension
• Insulin Resistance
• Obesity

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Blood Pressure, Diabetes | Phase 1 | Status: RECRUITING